Cochrane · systematic review · CD005010

Primary cryotherapy for localised or locally advanced prostate cancer

Jung, JH, Risk, MC, Goldfarb, R, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library

UrologyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
1
Included studies
NR
No studies 1 · 14.3%Ungraded 0 · 0%Very low 6 · 85.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Whole gland primary cryotherapy compared to external beam radiotherapy (EBRT) for localised or locally advanced prostate cancer (long‐term outcomes)

7 questions
OutcomeEffectEvidenceStatus / GRADE
Time to death from prostate cancer (absolute effects: disease‐specific mortality)
Whole gland primary cryotherapy vs external beam radiotherapy (EBRT)
HR 1 [0.11, 9.45]2 studies · 293 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Quality of life ‐ urinary function
Whole gland primary cryotherapy vs external beam radiotherapy (EBRT)
no estimate extracted1 study · 195 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Quality of life ‐ bowel function
Whole gland primary cryotherapy vs external beam radiotherapy (EBRT)
no estimate extracted1 study · 195 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Quality of life ‐ sexual function
Whole gland primary cryotherapy vs external beam radiotherapy (EBRT)
no estimate extracted1 study · 195 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Major adverse events
Whole gland primary cryotherapy vs external beam radiotherapy (EBRT)
RR 0.91 [0.47, 1.78]2 studies · 293 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Time to death from any cause (absolute effects: overall mortality)
Whole gland primary cryotherapy vs external beam radiotherapy (EBRT)
HR 0.99 [0.05, 18.79]2 studies · 293 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Secondary interventions for treatment failure ‐ not reported
Whole gland primary cryotherapy vs external beam radiotherapy (EBRT)
no estimate extractedNRNo studies